Lipid Legends: Reducing Risk Through LDL-C Management and The Role of Lp(a) in Cardiovascular Care and the Role of Lp(a) and Potential Impact of Emerging Therapies

1.00CME

1.00ABIM MOC

60MINS

Overview

Provider Statement

This continuing education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by educational funding provided by Amgen; Arrowhead Pharmaceuticals, Inc.; and Novartis Pharmaceuticals Corporation.

Activity Description

The Lipid Legends podcast series highlights accomplished lipid specialists to highlight clinical challenges and provide actionable insights into disorders. In these episodes, experts in the field review the importance of early and sustained LDL-C lowering in high-risk patients and describe the role of Lp(a) and its impact on clinical outcomes.

Target Audience

The intended audience for this activity is cardiologists, lipidologists, primary care physicians, and allied health professionals involved in the management of patients with dyslipidemia.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

Review current recommendations for cardiovascular risk assessment and LDL-C treatment goals in high-risk patients.
Describe the role of Lp(a) in atherogenesis and the potential impact of emerging therapies.

Activity Chair

James A. Underberg, MD, MS, FACP, FACPM, FASH, MNLA
Clinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for CV Prevention
Director, Bellevue Hospital Lipid Clinic
Past-President, National Lipid Association
Past-President, American Board of Clinical Lipidology
Diplomate, American Board of Clinical Lipidology
New York, NY

Faculty

Pam R. Taub, MD, FACC, FASPC
Step Family Director's Endowed Chair
Director of Preventive Cardiology
Director of Step Family Cardiovascular Rehabilitation and Wellness Center
Professor of Medicine
UC San Diego Health System
Division of Cardiovascular Medicine
La Jolla, CA

Howard Weintraub, MD
Clinical Professor of Medicine, NYU Grossman of Medicine
Clinical Director, NYU Center for the Prevention of Cardiovascular Disease
Associate Director, NYU Preventive Cardiology Fellowship Program
New York, NY

Planner/Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation

ACCME Jointly accredited In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participants who opt in by providing their ABIM ID and DOB (MM/DD) will earn MOC points equivalent to the amount of CME credits claimed for the activity.

This enduring material is approved for 1 year from the date of original release, December 15, 2025, to December 14, 2026.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objective, answer the polling and pretest questions, listen to the podcast, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 of the 3 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

In addition to providing a downloadable certificate, CME Providers accredited by the Accreditation Council for Continuing Medical Education (ACCME) have the ability to transmit CME credit data for all US physicians to an online repository, the ACCME Program and Activity Reporting System (PARS). CME credit data submitted to PARS can be viewed, managed, and tracked by US physicians in "CME Passport," a free, centralized web application.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s)

James A. Underberg, MD, MS, FACP, FACPM, FASH, MNLA
Advisor: Ionis, NewAmsterdam
Consultant: Amgen
Speaker Contracted by Ineligible Company: Amgen, Arrowhead, Chiesi, Esperion, Ionis, Regeneron

Pam R. Taub, MD, FACC, FASPC
Consultant: Amarin, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Cleerly, CSL Behring, Edwards, Esperion, Lexicon, Lilly, Medtronic, Merck, Novartis, NewAmsterdam, Novo Nordisk, Roche
Individual Stocks (publicly traded): Epirium Bio

Howard Weintraub, MD
Consultant: Novo Nordisk
Speaker Contracted by Ineligible Company: Amgen, Lilly, Novartis

Planner/Reviewer reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

ADA Compliance

In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this Podcast is available upon request. Requests should include the complete activity title and emailed to CME@VindicoCME.com. Requests will be honored within 3 to 5 business days.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2025 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.